[HTML][HTML] The different autophagy degradation pathways and neurodegeneration

A Fleming, M Bourdenx, M Fujimaki, C Karabiyik… - Neuron, 2022 - cell.com
The term autophagy encompasses different pathways that route cytoplasmic material to
lysosomes for degradation and includes macroautophagy, chaperone-mediated autophagy …

The coming of age of chaperone-mediated autophagy

S Kaushik, AM Cuervo - Nature reviews Molecular cell biology, 2018 - nature.com
Chaperone-mediated autophagy (CMA) was the first studied process that indicated that
degradation of intracellular components by the lysosome can be selective—a concept that is …

Impaired dopamine release in Parkinson's disease

KML Cramb, D Beccano-Kelly, SJ Cragg… - Brain, 2023 - academic.oup.com
Parkinson's disease is the second most common neurodegenerative disease and yet the
early pathophysiological events of the condition and sequences of dysfunction remain …

To degrade or not to degrade: mechanisms and significance of endocytic recycling

PJ Cullen, F Steinberg - Nature reviews Molecular cell biology, 2018 - nature.com
Newly endocytosed integral cell surface proteins are typically either directed for degradation
or subjected to recycling back to the plasma membrane. The sorting of integral cell surface …

Autophagy in Parkinson's disease

X Hou, JO Watzlawik, FC Fiesel, W Springer - Journal of molecular biology, 2020 - Elsevier
Impaired protein homeostasis and accumulation of damaged or abnormally modified protein
are common disease mechanisms in many neurodegenerative disorders, including …

Mutant glucocerebrosidase impairs α-synuclein degradation by blockade of chaperone-mediated autophagy

SH Kuo, I Tasset, MM Cheng, A Diaz, MK Pan… - Science …, 2022 - science.org
The most common genetic risk factors for Parkinson's disease (PD) are a set of
heterozygous mutant (MT) alleles of the GBA1 gene that encodes β-glucocerebrosidase …

Mitochondrial dysfunction in Parkinson's disease

A Bose, MF Beal - Journal of neurochemistry, 2016 - Wiley Online Library
Parkinson's disease (PD) is the second most common neurodegenerative disease. About
2% of the population above the age of 60 is affected by the disease. The pathological …

Selective autophagy as a potential therapeutic target for neurodegenerative disorders

A Scrivo, M Bourdenx, O Pampliega… - The Lancet …, 2018 - thelancet.com
Cells rely on surveillance systems such as autophagy to handle protein alterations and
organelle damage. Dysfunctional autophagy, an evolutionarily conserved cellular …

Understanding dopaminergic cell death pathways in Parkinson disease

PP Michel, EC Hirsch, S Hunot - Neuron, 2016 - cell.com
Parkinson disease (PD) is a multifactorial neurodegenerative disorder, the etiology of which
remains largely unknown. Progressive impairment of voluntary motor control, which …

Defects in trafficking bridge Parkinson's disease pathology and genetics

A Abeliovich, AD Gitler - Nature, 2016 - nature.com
Parkinson's disease is a debilitating, age-associated movement disorder. A central aspect of
the pathophysiology of Parkinson's disease is the progressive demise of midbrain dopamine …